Nucleus® Hybrid Cochlear Implant
FDA premarket approval P130016/S055 · decided 2023-12-13
Approval details
- PMA number
- P130016
- Supplement
- S055
- Supplement type
- 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- Nucleus® Hybrid Cochlear Implant
- Generic name
- Cochlear implant with combined electrical stimulation and acoustic amplification
- Applicant
- Cochlear Americas
- Date received
- 2023-11-13
- Decision date
- 2023-12-13
- Days to decision
- 30 days
- Decision code
- OK30
- Product code
- PGQ
- Advisory committee
- Ear, Nose, Throat
- Expedited review
- No
- Location
- Lone Tree, CO
- Statement
- introduction of new manufacturing processes for making battery subcomponents of the CP1000 and CP1100 sound processors
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.